Fièvre méditerranéenne familiale en 2020

Heller, 1955, Familial Mediterranean fever, Harefuah, 48, 91 French FMF Consortium, 1997, A candidate gene for familial Mediterranean fever, Nat Genet, 17, 25, 10.1038/ng0997-25 Sood, 1997, Construction of a 1-Mb restriction-mapped cosmid contig containing the candidate region for the familial Mediterranean fever locus (MEFV) on chromosome 16p 13.3, Genomics, 42, 83, 10.1006/geno.1997.4629 Goldfinger, 1972, Colchicine for familial Mediterranean fever, N Engl J Med, 287, 1302, 10.1056/NEJM197212212872514 Daniels, 1995, Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel, Am J Med Genet, 55, 311, 10.1002/ajmg.1320550313 Ozen, 1998, Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study, J Rheumatol, 25, 2445 Rom, 2018, Protracted febrile myalgia syndrome treated with pulse of corticosteroids, Semin Arthritis Rheum, 47, 897, 10.1016/j.semarthrit.2017.10.008 Mercan, 2016, Rapid resolution of protracted febrile myalgia syndrome with anakinra: report of two cases, Mod Rheumatol, 26, 458, 10.3109/14397595.2014.882221 Unal, 2010, Evaluation of common mutations in the Mediterranean fever gene in multiple sclerosis patients: is it a susceptibility gene?, J Neurol Sci, 294, 38, 10.1016/j.jns.2010.04.008 Giancane, 2015, Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever, Ann Rheum Dis, 74, 635, 10.1136/annrheumdis-2014-206844 Sönmez, 2016, Familial Mediterranean fever: current perspectives, J Inflamm Res, 9, 13 Touitou, 2007, Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever, Arthritis Rheum, 56, 1706, 10.1002/art.22507 Livneh, 1997, Criteria for the diagnosis of familial Mediterranean fever, Arthritis Rheum, 40, 1879, 10.1002/art.1780401023 Yalçinkaya, 2009, A new set of criteria for the diagnosis of familial Mediterranean fever in childhood, Rheumatology (Oxford), 48, 395, 10.1093/rheumatology/ken509 Xu, 2014, Innate immune sensing of bacterial modifications of Rho GTPases by the pyrin inflammasome, Nature, 513, 237, 10.1038/nature13449 Park, 2016, Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS, Nat Immunol, 17, 914, 10.1038/ni.3457 Apostolidou, 2016, Neutrophil extracellular traps regulate IL-1β-mediated inflammation in familial Mediterranean fever, Ann Rheum Dis, 75, 269, 10.1136/annrheumdis-2014-205958 Abbara, 2017, Association of hidradenitis suppurativa and familial Mediterranean fever: a case series of 6 patients, Joint Bone Spine, 84, 159, 10.1016/j.jbspin.2016.02.021 Langevitz, 1997, Seronegative spondyloarthropathy in familial Mediterranean fever, Semin Arthritis Rheum, 27, 67, 10.1016/S0049-0172(97)80007-8 Kaşifoğlu, 2009, The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis, Clin Rheumatol, 28, 41, 10.1007/s10067-008-0980-3 Erden, 2018, Increased psoriasis frequency in patients with familial Mediterranean fever, Ups J Med Sci, 123, 57, 10.1080/03009734.2017.1423425 Booth, 1998, Pyrin/marenostrin mutations in familial Mediterranean fever, QJM, 91, 603, 10.1093/qjmed/91.9.603 Stoffels, 2014, MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease, Ann Rheum Dis, 73, 455, 10.1136/annrheumdis-2012-202580 Moghaddas, 2017, A novel pyrin-associated autoinflammation with neutrophilic dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever, Ann Rheum Dis, 76, 2085, 10.1136/annrheumdis-2017-211473 Hong, 2019, Autoinflammation due to homozygous S208 MEFV mutation, Ann Rheum Dis, 78, 571, 10.1136/annrheumdis-2018-214102 Boursier, 2019, The changing concepts regarding the Mediterranean fever gene: toward a spectrum of pyrin-associated autoinflammatory diseases with variable heredity, J Pediatr, 209, 10.1016/j.jpeds.2019.02.039 Zemer, 1986, Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever, N Engl J Med, 314, 1001, 10.1056/NEJM198604173141601 Dinarello, 1974, Colchicine therapy for familial mediterranean fever. A double-blind trial, N Engl J Med, 291, 934, 10.1056/NEJM197410312911804 Zemer, 1974, A controlled trial of colchicine in preventing attacks of familial Mediterranean fever, N Engl J Med, 291, 932, 10.1056/NEJM197410312911803 Gao, 2016, Site-specific phosphorylation and microtubule dynamics control pyrin inflammasome activation, Proc Natl Acad Sci U S A, 113, E4857, 10.1073/pnas.1601700113 Ozen, 2016, EULAR recommendations for the management of familial Mediterranean fever, Ann Rheum Dis, 75, 644, 10.1136/annrheumdis-2015-208690 De Benedetti, 2018, Canakinumab for the treatment of autoinflammatory recurrent fever syndromes, N Engl J Med, 378, 1908, 10.1056/NEJMoa1706314 Ugurlu, 2017, Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever, Orphanet J Rare Dis, 12, 105, 10.1186/s13023-017-0642-0 Sohar, 1967, Familial Mediterranean fever. A survey of 470 cases and review of the literature, Am J Med, 43, 227, 10.1016/0002-9343(67)90167-2 Akar, 2012, Familial Mediterranean fever: risk factors, causes of death, and prognosis in the colchicine era, Medicine (Baltimore), 91, 131, 10.1097/MD.0b013e3182561a45 Yilmaz, 2003, Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients, Turk J Pediatr, 45, 198 Balci, 2002, MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study, Nephrol Dial Transplant, 17, 1921, 10.1093/ndt/17.11.1921 Verine, 2007, Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response, Hum Pathol, 38, 1798, 10.1016/j.humpath.2007.04.013 Ben-Chetrit, 1993, Colchicine inhibits spermatozoal motility in vitro, Int J Fertil Menopausal Stud, 38, 301 Götestam Skorpen, 2016, The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation, Ann Rheum Dis, 75, 795, 10.1136/annrheumdis-2015-208840